Compare Intuitive Surgical, Inc. (ISRG) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Strategy Inc. — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Strategy Inc. trades at $154.34 (market cap $60.40B). The key difference: Intuitive Surgical, Inc. is far larger — about 2.4× Strategy Inc.'s market cap, and Strategy Inc. is more actively traded (23,421,830 versus 2,529,814). Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Strategy Inc. for 112 Days on average.
| ISRG | MSTR | |
|---|---|---|
Market Cap | $146.76B | $60.40B |
Volume | 2,529,814 | 23,421,830 |
Sector | Health | Technology |
52-Week High | $592.85 | $315.47 |
52-Week Low | $332.02 | $82.31 |
Typical Hold Time | 84 Days | 112 Days |
Enterprise Value | $141.54B | $79.16B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
MSTR stock trades at $151.47, down 1.24% on the day, with a bullish technical signal and key support at $148. The company reported a net loss of $3.85 billion in 2025, with a negative net income margin of -6,102.96%, while analyst consensus remains positive with a $253.36 price target. Recent news highlights Citigroup doubling its price target to $240 amid a 35.67% one-month stock surge.
Outlook is mixed: strong analyst buy ratings and Bitcoin-linked optimism offer upside potential, but persistent losses, high debt, and volatile cash flows pose significant risks. Investors should weigh the bullish sentiment against fundamental weaknesses in profitability and substantial financial leverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
